Conavi Medical Corp.
CNVI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 131.44% | -97.46% | -24.44% | -84.48% | -90.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 131.44% | -97.46% | -24.44% | -84.48% | -90.75% |
| Cost of Revenue | -- | -- | -92.64% | -99.79% | -113.33% |
| Gross Profit | -7.43% | -96.91% | 818.56% | 205.66% | 667.42% |
| SG&A Expenses | 48.08% | 41.87% | -10.69% | -44.36% | -6.49% |
| Depreciation & Amortization | -7.07% | -10.65% | -17.50% | -9.56% | -24.43% |
| Other Operating Expenses | -- | 54.13% | -83.52% | -- | -- |
| Total Operating Expenses | -11.09% | -35.64% | -19.45% | -50.09% | -22.24% |
| Operating Income | 12.62% | -2,019.77% | 19.07% | 48.54% | 15.53% |
| Income Before Tax | -58.12% | 61.39% | 58.17% | 72.97% | 58.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.12% | 61.39% | 58.17% | 72.97% | 58.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.12% | 61.39% | 58.17% | 72.97% | 58.71% |
| EBIT | 12.62% | -2,019.77% | 19.07% | 48.54% | 15.53% |
| EBITDA | 12.48% | -1,324.03% | 19.94% | 48.98% | 15.05% |
| EPS Basic | 29.88% | 79.81% | 96.66% | 97.57% | 94.25% |
| Normalized Basic EPS | 26.62% | 30.70% | 94.31% | 96.94% | 94.43% |
| EPS Diluted | 29.88% | 79.81% | 96.66% | 97.57% | 94.25% |
| Normalized Diluted EPS | 26.62% | 30.70% | 94.31% | 96.94% | 94.43% |
| Average Basic Shares Outstanding | 125.74% | 91.35% | 1,151.98% | 1,012.79% | 618.64% |
| Average Diluted Shares Outstanding | 125.74% | 91.35% | 1,151.98% | 1,012.79% | 618.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |